Organogenesis Holdings Inc.
ORGO
$5.01
-$0.01-0.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 49.32% | 16.25% | |||
| Total Other Revenue | 66.81% | -- | |||
| Total Revenue | 49.36% | 16.51% | |||
| Cost of Revenue | 31.20% | 16.47% | |||
| Gross Profit | 56.20% | 16.52% | |||
| SG&A Expenses | 7.34% | 1.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.08% | 4.64% | |||
| Operating Income | 304.66% | 46.33% | |||
| Income Before Tax | 278.81% | 54.10% | |||
| Income Tax Expenses | 83.33% | 64.81% | |||
| Earnings from Continuing Operations | 329.63% | 50.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 329.63% | 50.16% | |||
| EBIT | 304.66% | 46.33% | |||
| EBITDA | 532.23% | 60.64% | |||
| EPS Basic | 280.88% | 62.98% | |||
| Normalized Basic EPS | 323.94% | 47.74% | |||
| EPS Diluted | 271.88% | 62.57% | |||
| Normalized Diluted EPS | 317.10% | 47.74% | |||
| Average Basic Shares Outstanding | 0.02% | 0.45% | |||
| Average Diluted Shares Outstanding | 3.14% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||